Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2016 Financial Results
HOPKINTON, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases, today …